The Cytokine Portion of p43 Occupies a Central Position within the Eukaryotic Multisynthetase Complex*

Multicellular eukaryotes contain a macromolecular assembly of nine aminoacyl-tRNA synthetase activities and three auxiliary proteins. One of these, p43, is the precursor of endothelial monocyte-activating polypeptide II (EMAP II), an inflammatory cytokine involved in apoptotic processes. As a step toward understanding this paradoxical association, the EMAP II portion of p43 has been localized within the rabbit reticulocyte multisynthetase complex. Immunoblot analysis demonstrates strong reaction of anti-EMAP II antiserum with p43, as well as cross-reactivity with isoleucyl-tRNA synthetase. Electron microscopic images of immunocomplexes show two antibody binding sites. The primary site is near the midpoint of the multisynthetase complex at the intersection of the arms with the base. This site near the lower edge of the central cleft is assigned to the C-terminal cytokine portion of p43. The secondary site of antibody binding is in the base of the particle and maps the location of isoleucyl-tRNA synthetase. These data allow refinement of the three-domain model of polypeptide distribution within the multisynthetase complex. Moreover, the central location of p43/EMAP II suggests a role for this polypeptide in optimizing normal function and in rapid disruption of essential cellular machinery when apoptosis is signaled.

[1]  P. Vandenabeele,et al.  The endothelial monocyte‐activating polypeptide II (EMAP II) is a substrate for caspase‐7 , 2000, FEBS letters.

[2]  S. Libutti,et al.  Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. , 1999, Cancer research.

[3]  S. Martinis,et al.  Aminoacyl‐tRNA synthetases: a family of expanding functionsMittelwihr, France, October 10–15, 1999 , 1999, The EMBO journal.

[4]  Jun Li,et al.  Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells , 1999, The Journal of experimental medicine.

[5]  K. Shiba,et al.  Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA Synthetase* , 1999, The Journal of Biological Chemistry.

[6]  J. Dignam,et al.  Immunoelectron Microscopic Localization of Glutamyl-/ Prolyl-tRNA Synthetase within the Eukaryotic Multisynthetase Complex* , 1999, The Journal of Biological Chemistry.

[7]  S. Rho,et al.  Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Weiner,et al.  A Deadly Double Life , 1999, Science.

[9]  M. T. Norcum Ultrastructure of the eukaryotic aminoacyl-tRNA synthetase complex derived from two dimensional averaging and classification of negatively stained electron microscopic images. , 1999, FEBS letters.

[10]  H. Schluesener,et al.  Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis , 1999, Acta Neuropathologica.

[11]  M. Siatecka,et al.  Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. , 1999, Journal of molecular biology.

[12]  S. Wolin,et al.  The trials and travels of tRNA. , 1999, Genes & development.

[13]  W. Risau,et al.  Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Warrington,et al.  Structural analysis of the multienzyme aminoacyl‐tRNA synthetase complex: A three‐domain model based on reversible chemical crosslinking , 1998, Protein science : a publication of the Protein Society.

[15]  M. Mirande,et al.  The p43 Component of the Mammalian Multi-synthetase Complex Is Likely To Be the Precursor of the Endothelial Monocyte-activating Polypeptide II Cytokine* , 1997, The Journal of Biological Chemistry.

[16]  S. Martinis,et al.  Aminoacyl-tRNA synthetases in biology and disease: new evidence for structural and functional diversity in an ancient family of enzymes. , 1997, RNA.

[17]  M. Mirande,et al.  The p18 component of the multisynthetase complex shares a protein motif with the β and γ subunits of eukaryotic elongation factor 1 , 1996 .

[18]  D. Yang Mammalian aminoacyl-tRNA synthetases. , 1996, Current topics in cellular regulation.

[19]  A. Wolfson,et al.  Aminoacyl-tRNA synthetases from higher eukaryotes. , 1994, Progress in nucleic acid research and molecular biology.

[20]  M. T. Norcum Isolation and electron microscopic characterization of the high molecular mass aminoacyl-tRNA synthetase complex from murine erythroleukemia cells. , 1989, The Journal of biological chemistry.

[21]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.